Hospital
Mid-Columbia Medical Center
Mid-Columbia Medical Center was paid $7.39M by Medicaid between Jan 2018 and Nov 2024, across 146 billing codes. Its largest line is 99285, emergency room visit (most serious) — 23% of everything it billed.
33Billing provider infoMID-COLUMBIA MEDICAL CENTER
THE DALLES, OR 97058
THE DALLES, OR 97058
33aNPI1306842752assigned 06/21/2005
33bProvider typeRural Acute Care Hospital
28Total paid$7.39M
24GClaims146,523
24DCodes billed146
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,528 | $2.05M | |
| 2019 | 19,162 | $900K | |
| 2020 | 12,627 | $566K | |
| 2021 | 23,059 | $999K | |
| 2022 | 25,491 | $1.29M | |
| 2023 | 16,820 | $928K | |
| 2024incomplete | 8,836 | $647K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 23% | 5,492 | 5,004 | $1.66M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 7,709 | 7,065 | $1.55M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 8,586 | 8,029 | $1.34M |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.6% | 1,957 | 1,580 | $337K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.8% | 4,502 | 3,803 | $205K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.2% | 4,778 | 2,286 | $164K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.1% | 2,395 | 1,861 | $155K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 17,215 | 14,401 | $147K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.9% | 3,653 | 3,078 | $137K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.8% | 182 | 174 | $131K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.7% | 2,800 | 2,491 | $129K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.3% | 2,036 | 842 | $95K |
134 more codes
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.3% | 2,231 | $93K |
| 80053 | Comprehensive metabolic panel | 1.2% | 8,087 | $85K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1.1% | 109 | $84K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,330 | $60K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,519 | $58K |
| G0378 | Hospital observation service, per hour | <1% | 178 | $43K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 777 | $39K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 487 | $37K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,441 | $33K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 286 | $32K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 89 | $30K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 822 | $29K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,164 | $27K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,074 | $27K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,088 | $25K |
| 94760 | <1% | 4,809 | $23K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 395 | $22K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,350 | $21K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 321 | $21K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 158 | $20K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 147 | $19K |
| 59025 | Fetal non-stress test | <1% | 132 | $18K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 49 | $18K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 643 | $18K |
| 94761 | <1% | 7,920 | $17K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 202 | $16K |
| 76830 | Ultrasound, transvaginal | <1% | 139 | $14K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 642 | $14K |
| 97161 | <1% | 281 | $14K | |
| 81001 | <1% | 2,290 | $14K | |
| 84484 | <1% | 701 | $13K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 119 | $13K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 137 | $12K |
| 97162 | <1% | 264 | $12K | |
| 96376 | <1% | 134 | $12K | |
| 93975 | <1% | 68 | $12K | |
| 80061 | Lipid panel | <1% | 738 | $11K |
| 87081 | <1% | 590 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,038 | $11K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,226 | $11K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 46 | $11K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,179 | $10K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,292 | $10K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 233 | $9K |
| 84703 | <1% | 570 | $9K | |
| 83690 | <1% | 409 | $9K | |
| 85027 | <1% | 1,256 | $9K | |
| 87186 | <1% | 224 | $8K | |
| 82728 | <1% | 364 | $7K | |
| 71045 | Radiologic examination, chest; single view | <1% | 147 | $7K |
| 85610 | <1% | 420 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 110 | $6K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,165 | $6K |
| 0012A | <1% | 239 | $5K | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 111 | $5K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 182 | $5K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 48 | $5K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 226 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,111 | $5K |
| 86803 | <1% | 128 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 154 | $5K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 12 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 120 | $5K |
| 0240U | <1% | 100 | $4K | |
| 73630 | <1% | 80 | $4K | |
| 73610 | <1% | 75 | $4K | |
| 83605 | <1% | 96 | $4K | |
| 0450 | Emergency room services | <1% | 96 | $4K |
| 0011A | <1% | 209 | $3K | |
| 81003 | <1% | 610 | $3K | |
| 73562 | <1% | 55 | $3K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,185 | $3K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 90 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 251 | $3K |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 60 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,399 | $2K |
| 73130 | <1% | 32 | $2K | |
| 87070 | <1% | 80 | $2K | |
| 87077 | <1% | 101 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 544 | $2K |
| 76536 | <1% | 12 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 221 | $2K |
| 86850 | <1% | 116 | $2K | |
| 80329 | <1% | 14 | $2K | |
| 94060 | <1% | 12 | $2K | |
| 86592 | <1% | 102 | $2K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 54 | $2K |
| 80320 | <1% | 31 | $2K | |
| 82948 | <1% | 347 | $2K | |
| 85379 | <1% | 38 | $1K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 350 | $1K |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 84 | $1K |
| 73030 | <1% | 28 | $1K | |
| 87088 | <1% | 117 | $1K | |
| 74018 | <1% | 16 | $1K | |
| 84153 | <1% | 47 | $1K | |
| 73110 | <1% | 17 | $1K | |
| 81025 | <1% | 234 | $1K | |
| 80076 | <1% | 100 | $835.86 | |
| 87040 | <1% | 20 | $798.75 | |
| 87807 | <1% | 15 | $796.80 | |
| 83735 | <1% | 109 | $746.29 | |
| J3535 | Drug administered through a metered dose inhaler | <1% | 15 | $653.37 |
| 88342 | <1% | 12 | $592.36 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 170 | $567.82 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 163 | $517.09 |
| 87340 | <1% | 33 | $516.88 | |
| 86900 | <1% | 45 | $487.52 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 181 | $484.30 |
| 97803 | <1% | 15 | $413.82 | |
| 85651 | <1% | 27 | $397.46 | |
| J7999 | Compounded drug, not otherwise classified | <1% | 29 | $365.30 |
| 82947 | <1% | 34 | $354.38 | |
| 86901 | <1% | 43 | $349.19 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 371 | $329.55 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 53 | $295.93 |
| 83540 | <1% | 17 | $279.20 | |
| 83550 | <1% | 17 | $277.98 | |
| 86787 | <1% | 14 | $271.08 | |
| 84439 | <1% | 16 | $269.24 | |
| 87210 | <1% | 17 | $221.01 | |
| 0353U | <1% | 26 | $207.92 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 12 | $202.53 |
| 82043 | <1% | 14 | $199.68 | |
| 86762 | <1% | 12 | $140.17 | |
| 81015 | <1% | 12 | $117.00 | |
| A9270 | Non-covered item or service | <1% | 15 | $67.11 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 100 | $35.55 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 12 | $26.11 |
| A9150 | Non-prescription drugs | <1% | 17 | $4.44 |
| 82962 | <1% | 38 | $3.22 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 1,554 | $0.10 |
| A7038 | Filter, disposable, used with positive airway pressure device | 0% | 54 | $0.00 |
| E0562 | Humidifier, heated, used with positive airway pressure device | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKING, KYLE (SERVICE AREA PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Portland Adventist Medical Center | Portland, OR | $12.73M |
| Mid-Columbia Medical Center | The Dalles, OR | $1.41M |
| Mid-Columbia Medical Center | The Dalles, OR | $1.16M |
| Mid-Columbia Medical Center | The Dalles, OR | $600K |
| Mid-Columbia Medical Center | The Dalles, OR | $454K |
| Mid-Columbia Medical Center | The Dalles, OR | $381K |
| Mid-Columbia Medical Center | The Dalles, OR | $48K |
| Mid-Columbia Medical Center | The Dalles, OR | $20K |
| Mid-Columbia Medical Center | The Dalles, OR | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.